Transgenic rabbits had reduced aortic and coronary atherosclerosis and reduced macrophages in atherosclerotic lesions, suggesting that enrichment of apoA-II in HDL particles has atheroprotective effects and that apoA-II may become a target for treating atherosclerosis [145]. This evidence concerns the gene APOA2 and atherosclerosis.